Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

399 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of severe steroid refractory ulcerative colitis.
Van Assche G, Vermeire S, Rutgeerts P. Van Assche G, et al. World J Gastroenterol. 2008 Sep 28;14(36):5508-11. doi: 10.3748/wjg.14.5508. World J Gastroenterol. 2008. PMID: 18810767 Free PMC article. Review.
Management of acute severe ulcerative colitis.
Van Assche G, Vermeire S, Rutgeerts P. Van Assche G, et al. Gut. 2011 Jan;60(1):130-3. doi: 10.1136/gut.2009.192765. Epub 2010 Oct 28. Gut. 2011. PMID: 21030524 Review.
Long-term outcome after infliximab for refractory ulcerative colitis.
Ferrante M, Vermeire S, Fidder H, Schnitzler F, Noman M, Van Assche G, De Hertogh G, Hoffman I, D'Hoore A, Van Steen K, Geboes K, Penninckx F, Rutgeerts P. Ferrante M, et al. Among authors: van steen k, van assche g. J Crohns Colitis. 2008 Sep;2(3):219-25. doi: 10.1016/j.crohns.2008.03.004. Epub 2008 May 16. J Crohns Colitis. 2008. PMID: 21172214
A panel to predict long-term outcome of infliximab therapy for patients with ulcerative colitis.
Arias MT, Vande Casteele N, Vermeire S, de Buck van Overstraeten A, Billiet T, Baert F, Wolthuis A, Van Assche G, Noman M, Hoffman I, D'Hoore A, Gils A, Rutgeerts P, Ferrante M. Arias MT, et al. Among authors: van assche g. Clin Gastroenterol Hepatol. 2015 Mar;13(3):531-8. doi: 10.1016/j.cgh.2014.07.055. Epub 2014 Aug 10. Clin Gastroenterol Hepatol. 2015. PMID: 25117777
The Modified Mayo Endoscopic Score (MMES): A New Index for the Assessment of Extension and Severity of Endoscopic Activity in Ulcerative Colitis Patients.
Lobatón T, Bessissow T, De Hertogh G, Lemmens B, Maedler C, Van Assche G, Vermeire S, Bisschops R, Rutgeerts P, Bitton A, Afif W, Marcus V, Ferrante M. Lobatón T, et al. Among authors: van assche g. J Crohns Colitis. 2015 Oct;9(10):846-52. doi: 10.1093/ecco-jcc/jjv111. Epub 2015 Jun 26. J Crohns Colitis. 2015. PMID: 26116558
Serum Neutrophil Gelatinase B-associated Lipocalin and Matrix Metalloproteinase-9 Complex as a Surrogate Marker for Mucosal Healing in Patients with Crohn's Disease.
de Bruyn M, Arijs I, De Hertogh G, Ferrante M, Van Assche G, Rutgeerts P, Vermeire S, Opdenakker G. de Bruyn M, et al. Among authors: van assche g. J Crohns Colitis. 2015 Dec;9(12):1079-87. doi: 10.1093/ecco-jcc/jjv148. Epub 2015 Sep 7. J Crohns Colitis. 2015. PMID: 26351381 Clinical Trial.
A Matrix-based Model Predicts Primary Response to Infliximab in Crohn's Disease.
Billiet T, Papamichael K, de Bruyn M, Verstockt B, Cleynen I, Princen F, Singh S, Ferrante M, Van Assche G, Vermeire S. Billiet T, et al. Among authors: van assche g. J Crohns Colitis. 2015 Dec;9(12):1120-6. doi: 10.1093/ecco-jcc/jjv156. Epub 2015 Sep 7. J Crohns Colitis. 2015. PMID: 26351386
399 results